8 stories
The intense demand for revolutionary weight loss drugs like Ozempic and Wegovy has inadvertently birthed a dangerous shadow industry. As legitimate supplies dwindle, desperate individuals are falling...
The fiercely competitive pharmaceutical world just got a lot more heated. The maker of blockbuster drug Ozempic has filed a lawsuit against a major competitor, alleging deceptive advertising practices...
As GLP-1 weight loss drugs take the world by storm, a significant side effect—muscle loss—is becoming impossible to ignore. New pharmaceutical breakthroughs aim to preserve lean mass, ensuring that th...
For countless individuals battling obesity, the journey doesn't end with weight loss; maintaining it often proves to be the biggest challenge. A new daily pill, Retatrutide, is showing significant pro...
Weight-loss injections like Wegovy and Mounjaro have been hailed as miracle cures, but their results are far from uniform. We dive into the biological and genetic reasons why these medications deliver...
In a significant move towards proactive cardiovascular care, the NHS is set to offer cutting-edge weight-loss injections to individuals who have previously suffered a heart attack and remain at high r...
A radical new pilot scheme is offering GP surgeries up to £3,000 to fast-track the rollout of weight-loss injections. As the NHS grapples with a burgeoning obesity crisis, the move marks a significant...
For Emily R., a weight-loss injection was meant to help shed pounds. What she didn't anticipate was that this journey would lead to a life-saving discovery, revealing an early-stage cancer that might...
